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Abstract
Alopecia areata (AA) is a common autoimmune disorder mostly presented as round patches of hair loss and subclassified
into alopecia totalis/alopecia universalis (AT/AU) based on the area of alopecia. Although AA is relatively common, only 5%
of AA patients progress to AT/AU, which affect the whole scalp and whole body respectively. To determine genetic
determinants of this orphan disease, we undertook whole-exome sequencing of 6 samples from AU patients, and 26
variants in immune-related genes were selected as candidates. When an additional 14 AU samples were genotyped for
these candidates, 6 of them remained at the level of significance in comparison with 155 Asian controls (p,1.9261023).
Linkage disequilibrium was observed between some of the most significant SNPs, including rs41559420 of HLA-DRB5
(p,0.001, OR 44.57) and rs28362679 of BTNL2 (p,0.001, OR 30.21). While BTNL2 was reported as a general susceptibility
gene of AA previously, HLA-DRB5 has not been implicated in AA. In addition, we found several genetic variants in novel
genes (HLA-DMB, TLR1, and PMS2) and discovered an additional locus on HLA-A, a known susceptibility gene of AA. This
study provides further evidence for the association of previously reported genes with AA and novel findings such as HLA-
DRB5, which might represent a hidden culprit gene for AU.
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Introduction
Alopecia areata (AA) is characterized by autoimmune-mediated
patchy hair loss. The alopetic patches can be multiple and coalesce
to diffuse hair loss over the scalp, even the whole body. Severe
forms of AA are named based on the body area affected by
alopecia and include alopecia totalis (AT; affecting the whole
scalp) and alopecia universalis (AU; affecting the entire body).
Although AA is fairly common, with the life-time risk being 1.7%
[1], progression to AT/AU is rare and only reported in 5% of AA
patients [2]. Clinically, the extent of hair loss is the most important
prognostic factor in AA [3]. Although more than 50% of classic
AA patients recover without treatment [4], less than 10% of
patients with AT/AU recover fully [5].
The underlying etiopathogenesis of AA has been revealed as an
autoimmune mechanism from multiple lines of studies. Histolog-
ically, AA is characterized by immune infiltrates surrounding the
hair follicle. Moreover, AA is responsive to immunosuppressive
therapies, further supporting an autoimmune basis for the disease
[6]. In addition, several genetic studies on AA have shown that
immune factors are key genetic components of AA. Early
association studies with selected candidate genes revealed that
AA or AT/AU is associated with several immune-related genes
including HLA-DQB1, MICA, PTPN22, IL1RN, AIRE, and
TRAF1/C5 [7–14]. Furthermore, HLA-DQB1, MICA, PTPN22,
IL1RN, and TRAF1/C5 were found to influence disease severity
[7,9–11,13,14]. Genetic susceptibility loci harboring murine
homologues of HLA have also been discovered in a C3H/HeJ
mouse model of AA [15]. In addition, recent genome-wide linkage
and association studies have identified several susceptibility loci
near, or within, genes related to autoimmunity, such as MICA and
BTNL2 [16–18].
Although previous studies have identified AA as an immune-
related disorder and have shown several genetic loci throughout
the genome, association studies for the most severe type of AA
(AU) have rarely been performed, especially using next-generation
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sequencing technology. Most rare missense genetic variations are
predicted to be deleterious and, thus, association studies with these
variants may be helpful in this regard [19]. Recent studies have
also suggested that the majority of variants seem to be rare, and
these rare variants are likely to be key determinants for the health
status of individuals [20,21]. Given that AU patients are rare and
have the most severe AA phenotype, identification of rare variants
with large effect sizes would be a good strategy to further elucidate
the genetic basis for this disease.
In this study, on the basis of the immune-related mechanism of
the disease, we conducted an exomic sequence analysis of
immune-related genes in AU patients with the aim of identifying




Ethical approval for the study was obtained from the relevant
Ethics Committees (The Institutional Review Board of the Seoul
National University Hospital). This study was conducted accord-
ing to Declaration of Helsinki principles. Written informed
consent was obtained before blood was taken from patients with
AU.
Study sample selection and DNA extraction
For this study, 20 patients with AU were recruited from the
outpatient clinic of Seoul National University Hospital. Overall
demographic data and clinical features are summarized in Table 1,
and detailed individual data are presented in Table S1. A
diagnosis of AU was based on any experience of whole body hair
loss in the participant’s lifetime, and involved areas other than the
scalp were eyebrow, axillary hair, and pubic hair (eyebrow only in
child). Genomic DNA was extracted from peripheral blood by
using QuickGene DNA whole blood kit with QuickGene-610L
equipment (Fujifilm, Tokyo, Japan). DNA concentrations were
measured by Nanodrop ND-1000 spectrophotometer (Nano-drop
Technologies, Delaware, USA).
Whole-exome sequencing of 6 individuals with alopecia
universalis
Exomic regions of DNA were captured by SureSelect Human
All Exon v.2 Kits (Agilent Technologies, California, USA) and
sequenced through HiSeq 2000 (Illumina, California, USA) in 6
samples among study subjects. All procedures followed the
manufacturer’s instructions. The generated reads were aligned to
the NCBI human reference genome build 37 (hg19) using the
Genomic Short-read Nucleotide Alignment Program alignment
tool [22]. Only positions having $8 uniquely aligned reads and
$20 mean quality score (Q score) were carried forward for further
analyses. Variant calling was performed according to the criteria
of our previous study [23], and all the variants called were
annotated by the RefSeq gene set and compared with dbSNP
build 132.
Filtration into functional candidate variants
In this study, we focused on the variants found in immune-
related genes. Candidate genes were categorized by gene ontology
by using DAVID [24] and only variants in immune-related genes
were collected. Among them, we selected nonsynonymous single
nucleotide polymorphisms (SNPs), coding sequence insertions/
deletions (indels), and canonical splice-site variants as pathogenic
candidates.
For further filtration, genotype frequencies of pathogenic
candidates were compared between patient and control groups
in both dominant and recessive models. The control samples used
for this study were as follows: (1) 59 Korean samples (8 from
whole-genome sequencing (WGS), 41 from whole-exome sequenc-
ing (WES)), (2) 56 Asian HapMap samples (10 from WGS, 46 from
WES), and (3) 40 Mongolian samples from WES. These controls
were selected from the Asian Genome Project of our group, and
58 of them were published in our previous studies [25,26].
Statistical comparisons were drawn using a non-parametric
method of Fisher’s exact test, and a p-value less than 0.05 was
used as a standard for the candidate selection. To reduce the
number of variants selected by chance, we further narrowed our
candidates into those shown in at least 2 patient samples.
Finally, we manually checked the coverage depth of each
variant and excluded variants showing deviated patterns of
coverage. The deviated pattern of coverage was defined as a
coverage depth ratio between the reference and variant alleles that
is either .0.5 or ,0.5 throughout the samples (Table S2).
Overall filtration steps above were summarized in Figure S1. In
addition to the candidates selected, rs28362679 in BTNL2 was
included since it is not only associated with MHC class II but also
previously highlighted as a susceptibility gene for the development
of AA [17].
Further genotyping in 14 additional alopecia universalis
patients and frequency comparison with control samples
The remaining variants were genotyped in the other 14 patient
samples with PCR and subsequent Sanger sequencing (Table S3).
Using Fisher’s exact test, the genotype frequency of each variant
was compared with that of 155 control samples in both dominant
and recessive models. For both analyses, the threshold level of
significance was set at a p-value lower than 1.9261023,
considering multiple testing of our selected candidates (n = 26).
For reference, the allele frequency of each variant in Asians was
also checked against the 1000 Genomes Project by using the
ENGINES program [27].
Table 1. Demographic data of enrolled patients.
Age, years 3–43 (mean: 15)
Gender, n Male 13 (65%)
Female 7 (35%)
Onset, n1 Early onset 15 (75%)




Nail dystrophy, n 6 (30%)




Thyroid disease 2 (10%)
Psoriasis 1 (5%)
1Based on the age at onset of , or $13 yr, patients were classified to the early-
onset group.
doi:10.1371/journal.pone.0053613.t001
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Linkage disequilibrium analysis
We explored the linkage disequilibrium (LD) structures among
final candidates to check if there were any crucial haplotypes
associated with AU. The genotypes of all 20 patient samples were
used for LD estimation, which was calculated by the Haploview
program (Version 4.2). We defined LD structure between SNPs
when an r2 value was higher than 0.3, and pairwise comparisons of
markers .500 kb apart were ignored.
Results
We sequenced exomic regions of 6 individuals with AU and
aligned the generated reads to the NCBI human reference genome
build 37 (Table 2). The percentage of covered bases in the bait
region was 84.7% on average (76.2–88.75%) with the mean
coverage depth of 69.16 (43.6–100.06). SNPs and short indels
were called according to the criteria set out in our previous study,
and annotated based on the RefSeq gene set and dbSNP build 132
[23]. The annotated SNPs and indels were filtered stepwise as
described in the methods, and narrowed down to 25 SNPs and 1
indel by excluding variants showing ambiguous patterns of
coverage depth in exome sequencing and a variant with PCR
failure (Table 3).
Next, we genotyped the final 26 candidates in additional 14 AU
samples by using PCR and subsequent Sanger sequencing method.
The frequency of each candidate was compared with that of
control samples in both dominant and recessive models (Table 3).
As a result, 6 out of 26 candidates had p-values less than
1.9261023. Although all these variants were novel as AA or AT/
AU susceptibility variants, BTNL and HLA-A had previously been
reported as genetic candidates for the development of AA [17,28].
To determine whether there were any haplotypes composed
within our candidate variants, we explored the LD structure
among them by using genotype data from our AU patients
(Table 4). As a result, we found 2 LD structures among 26
candidates; one included rs28362679, rs41559420, rs41542812,
and rs1049107, whilst the other included rs116897146 and
rs34531670 (r2.0.3). The first haplotype (unlike the second)
contained some significant SNPs, including rs41559420 of HLA-
DRB5 (p,0.001, OR 44.57) and rs28362679 of BTNL2 (p,0.001,
OR 30.21).
The HLA-DQB1 and C5 genes have been suggested as
susceptibility genes of AA previously [7,13]. Even though
rs41542812 of HLA-DQB1 (p = 0.015, OR 5.4) and C5
(p = 0.019, OR 4.0) did not reach the significance level of this
study, studies with larger sample sizes may alter the decisions for
these variants. In addition, involvement of the TRAF1/C5 locus in
the etiology of familial and severe AA was revealed in a recent
study [13].
Discussion
Our study revealed several immune-related susceptibility
variants for AU and the LD between some of the most significant
variants. Of the 2 statistically significant genes in the associated
combination of alleles, BTNL2 has already been associated with
the development of AA [17], while HLA-DRB5 has not previously
been implicated in the pathogenesis of this disease. The HLA-
DRB5 gene encodes the major histocompatibility complex, class II,
DR beta 5. This class II molecule plays an important role in the
immune system by presenting antigens in antigen-presenting cells.
The presence of a certain HLA gene might ensure more proficient
presentation of a particular autoantigen and, consequently, the
association of HLA genes with autoimmune diseases has received a
great deal of attention. The associations of HLA-DRB5 with
autoimmune disorders such as multiple sclerosis [29], systemic
sclerosis [30], and rheumatic heart disease [31] have been
reported. Given the assumed autoimmune development of AA,
we hypothesized that HLA-DRB5 might also be responsible for the
development of AA.
Although numerous previous studies including 2 genome-wide
association studies (GWAS) have been performed, the association
of HLA-DRB5 with AA has not yet been reported to our
knowledge. In this study, however, the nonsynonymous SNP
(rs41559420) in HLA-DRB5 was most significant in the compar-
ative analysis of 20 AU patients with controls, showing the highest
odds ratio among candidates (Table 3). This may indicate the
existence of different pathological mechanisms between AU and
AA, or these kinds of variants may have been missed, or not
reported, in the previous studies because of their considerable
rarity. Indeed, the Illumina 610 K and 550 K, used in the
previous 2 GWAS studies performed on AA, do not contain this
SNP [17,18]. Even if these arrays did include it, it would not have
been analyzed since SNPs with low minor allele frequency (MAF)
are usually excluded during the quality control process (Table 3,
see the allele frequencies in the columns of MAF).
In addition to BTNL2, we also replicated another gene, HLA-A,
to be associated with AA at the gene level [28]. Besides these, other
variants found in this study were all located in novel genes,
including HLA-DMB, PMS2, and TLR1. The HLA-DMB gene
encodes HLA class II beta chain paralogue like HLA-DRB5 [32]
and this molecule is an important component of the adaptive
immune system. TLR1, which plays fundamental roles in innate
immunity [33,34], was also first reported in AA. Since both
adaptive and innate immunoregulatory genes are known to be
Table 2. Sequencing summary of patient samples.
Samples Total reads Uniquely aligned reads
% Covered bait
bases1 ($1)
% Covered bait bases
($8)
Mean coverage depth
in bait regions (x)
AU01 65,959,668 57,329,095 96.07 87.25 58.65
AU02 41,309,992 35,686,769 94.06 79.73 35.32
AU03 71,009,718 61,311,833 96.23 87.72 62.09
AU04 53,085,782 46,056,902 95.58 84.9 46.53
AU05 74,426,242 64,677,337 96.39 88.34 65.39
AU06 121,993,380 75,311,600 89.23 76.22 76.66
1Bases within the bait region defined as the region covered by more than one capture probe.
doi:10.1371/journal.pone.0053613.t002
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involved in the pathogenesis of AA [17], these novel findings
warrant further research. Mutations in PMS2 are important in the
progression of human cancer [35,36], and deficiency of human
PMS2 is associated with impaired immunoglobulin class switch
recombination [37]. The association of cancer immunology
components with AA requires further validation.
In Table S4, we list all the pathogenic candidates satisfying the
candidate selection criteria of this study, regardless of gene
ontology, for the researchers interested in AA or AT/AU. Even if
only the immune-related variants were selected for this study,
there could be more explanations on disease development other
than autoimmunity, or unknown genes participating in the
immune system. Furthermore, as AA or AT/AU is a well-known
complex disorder determined by multiple genetic and environ-
mental factors, these listed variant would be open to a diversity of
interpretations when more patient samples are sequenced or
various studies are conducted on different points of view.
Genes involved in the hair development can be good examples
of such possible candidates for the AU pathogenesis, other than
immune-related genes. Previous studies have reported several
genes for hair development, such as HR, LHX2 [38], and genes
involved in Wnt signaling [39], Sonic hedgehog (Shh) signaling
[40], and bone morphogenetic protein (BMP) signaling pathways
[41]. Among the pathogenic candidates in Table S4, we found 3
variants in Wnt signaling genes, including AXIN2, POSTN, and
Table 3. Association between alopecia universalis and selected markers in the case-control analysis.
Dominant Recessive
Variant Gene Risk allele p-value OR p-value OR 1000 Genomes1 NGS Controls2
rs41559420 HLA-DRB5 A ,0.001 44.571 ,0.001 - 0.014 0.005
rs28362679 BTNL2 A ,0.001 30.214 - - 0.021 0.007
rs113337937 HLA-A del ,0.001 18.857 - - - 0.088
rs116375983 HLA-DMB T ,0.001 8.917 0.159 3.861 - 0.14
rs1805323 PMS2 T 0.001 8.125 0.332 1.683 0.348 0.31
rs117033348 TLR1 G 0.001 7.754 - - 0.014 0.032
rs1126477 LTF T 0.002 6.847 0.193 2.19 0.4 0.292
rs2277244 DMBT1 T 0.003 6.074 - - 0.079 0.049
rs2297950 CHIT1 T 0.006 4.024 0.017 7.667 0.295 0.174
rs17130745 GBP4 C 0.009 6.083 0.115 - 0.033 0.026
rs78108426 CIITA A 0.009 4.667 - 0 0.131 0.069
rs41542812 HLA-DQB1 G 0.015 5.4 0.01 - 0.058 0.037
rs75268750 C5 A 0.019 4 - - 0.072 0.048
rs161704 IL31RA A 0.023 3.16 0.18 2.156 0.358 0.295
rs2276872 CD96 C 0.024 3.025 0.387 2.667 0.157 0.116
rs17847215 INPPL1 C 0.036 4 - - 0.075 0.048
rs2273346 MASP2 G 0.046 2.522 0.081 4.059 0.175 0.184
rs2738047 DEFB1 T 0.053 5.153 - - 0.01 0.017
rs4304840 CLEC4D G 0.06 2.413 - 0 0.154 0.14
rs116306892 MICA C 0.084 2.227 0.069 4.553 - 0.153
rs34531670 KIR3DP1 C 0.106 2.114 0.248 2.593 - 0.14
rs4911290 C20orf185 A 0.223 3.2 0.494 1.143 0.248 0.288
rs116897146 KIR3DP1 C 0.226 1.66 0.541 1.495 - 0.139
rs1799945 HFE G 0.289 2.254 - - 0.024 0.023
rs1049107 HLA-DQB1 T 0.3 1.548 0.094 3.625 - 0.161
rs17611 C5 T 0.393 1.404 0.024 2.949 0.418 0.497
Abbreviations: OR, odds ratio; SNP, single nucleotide polymorphism; MAF, minor allele frequency; del, deletion; NGS, next-generation sequencing.
1Minor allele frequency of each variant in 1000 Genomes Phase I [27].
2Minor allele frequency of each variant in 155 controls used in this study.
doi:10.1371/journal.pone.0053613.t003
Table 4. Linkage disequilibrium estimation among
candidates (r2.0.3).
Chromosome Variant 1 Variant 2 r2 D9
6 rs28362679 rs41559420 0.41 1
rs41542812 0.61 1
rs1049107 0.47 1
rs41559420 rs41542812 0.68 1
rs1049107 0.49 0.74
rs41542812 rs1049107 0.77 1
19 rs116897146 rs34531670 0.75 1
doi:10.1371/journal.pone.0053613.t004
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VCAN. Although these were not included for this study, additional
research might determine their roles in AU pathogenesis.
We acknowledge that the sample size in our study is relatively
small, and only 6 samples were sequenced by next-generation
sequencing technology. Small sample sizes have higher probability
for false positives, which accidentally co-occur in case samples.
However, given that causative variants in these extreme pheno-
types are likely to be quite rare but may have large effect sizes,
targeted and stepwise approaches may minimize this limitation.
First, as the pathogenesis of AA is thought to be autoimmune, only
variants in immune-related genes were concerned for further
validation study. Second, we selected candidate variants that could
affect the functions of the encoded proteins through altering amino
acid sequences. Third, we selected candidate variants shown in at
least 2 samples and manually checked the coverage depth of each
position in an attempt to increase reliability and reduce the false
positive calls. Throughout these filtration steps, our study could
select several candidate variants from exome sequencing results
and successfully validate 6 of them in our study subjects.
This study has another limitation for suggesting decisive
candidates for AU development; a lack of replication. However,
14 samples, which were additionally sequenced for final analyses,
were independent from the first 6 samples. When these 14 samples
were analyzed separately, 8 candidates, including the 6 variants
which were significant at last, showed similar levels of significance
with those in the candidate selection analysis (p,0.05, Table S5).
These results enhance the possibility that our candidates might be
causative for AU pathogenesis, even though future studies on
similar or different populations are necessary to confirm our
findings.
To identify genetic determinants in patients with the most
severe AA phenotype, we conducted an association study after
completion of WES and discovered candidate variants by using a
stepwise filtering approach. Through the WES approach, several
studies have successfully discovered the causative genes in rare
Mendelian disorders [42,43]. Furthermore, exome sequencing
followed by a subsequent association study was recently performed
in a small population with extreme phenotypes and showed the
utility of next-generation sequencing in searching for causative
variants in complex traits [44]. Now, due to the advance of high-
throughput sequencing technologies, it is predicted that these
approaches will potentially replace array-based technologies and
open up a new era of genetic research [45]. The current findings
are another example of the potential use of sequencing technol-
ogies to identify causative candidate genes in complex disorders.
In conclusion, through an exomic sequence analysis on
immune-related genes, we found several candidate variants and
haplotypes associated with AU. This study provides further
evidence for the involvement of immune-related genes in the
development of AA and identifies novel candidates such as HLA-
DRB5, which may play a previously unrecognized role in the
pathogenesis of the disease.
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